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 CURRENTOPINION HIV subtype diversity worldwide
Nicholas Bbosaa, Pontiano Kaleebua,b, and Deogratius Ssemwangaa,b
Purpose of review
To provide a summary of the current data on the global HIV subtype diversity and distribution by region.
HIV is one of the most genetically diverse pathogens due to its high-mutation and recombination rates,
large population size and rapid replication rate. This rapid evolutionary process has resulted in several HIV
subtypes that are heterogeneously globally distributed.
Recent findings
Subtype A remains the most prevalent strain in parts of East Africa, Russia and former Soviet Union
countries; subtype B in Europe, Americas and Oceania; subtype C in Southern Africa and India;
CRF01_AE in Asia and CRF02_AG in Western Africa. Recent studies based on near full-length genome
sequencing highlighted the growing importance of recombinant variants and subtype C viruses.
Summary
The dynamic change in HIV subtype distribution presents future challenges for diagnosis, treatment and
vaccine design and development. An increase in recombinant viruses suggests that coinfection and
superinfection by divergent HIV strains has become more common necessitating continuous surveillance to
keep track of the viral diversity. Cheaper near full-length genome sequencing approaches are critical in
improving HIV subtype estimations. However, missing subtype data and low sequence sampling levels are
still a challenge in some geographical regions.
Video abstract
http://links.lww.com/COHA/A14.
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INTRODUCTION
As of 2017, there were 36.9 million people living with
HIV worldwide with a majority of these infections in
sub-Saharan Africa [1]. AIDS is a global pandemic
caused by two genetically diverse lentiviruses, HIV-1
andHIV-2 [2], that were introduced throughmultiple
cross-species transmissions of simian immunodefi-
ciency viruses from nonhuman primates to humans.
These distinct zoonotic viral transmissions gave rise to
separate HIV-1 groupsM (Major), O (Outlier), N (non-
M, non-O) and themost recent group P [2]. The origin
ofHIV-1hasbeendocumentedaroundKinshasa in the
presentdayDemocraticRepublicofCongoaround the
1920s fromwhere it spread along a transport network
to other areas in sub-Saharan Africa, West Africa,
Europe and the rest of theworld [3]. This global spread
was marked by a geographically defined distribution
of several genetically distinct viruses. For instance,
subtype B became prevalent in almost all parts of
Europe and the Americas while a variety of subtypes
and intersubtype recombinants are found in Africa
with the highest diversity reported in West Central
Africa. Whereas group M viruses have dominated the
global HIV pandemic since its inception, other group
N,OandPviruses havenot beendisseminatedwidely.
Group M viruses are further subdivided into nine
subtypes (A-D, F-H, J, K) [2]. The genetic distance
within a subtype canbe between 15 and20%,whereas
genetic distances across subtypes are usually 25 and
35% [4]. HIV-2 remains largely restricted to the
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western part of Africa although viral introductions
have been reported elsewhere in Europe (Portugal
and France), India and the United States of America
[5]. HIV-2 has also been documented to be less infec-
tious than HIV-1 [6,7]; it is comprised of at least nine
groups (formerly referred to as subtypes; A to I) of
which groups A and D are presently circulating [5].
HIV-2 subtype data is still limited and only a few
recombinants have been described [5,8].
CIRCULATING RECOMBINANT FORMS
Recombination is an important phenomenon for
viral diversification that allows the virus to evade
the host immune system and antiretroviral treat-
ment [9]. A recombinant is a viral sequence that has
regions from two or more distinct parental strains
[10]. A circulating recombinant form or circulating
recombinant form (CRF) is a combination of viral
genomes of different subtypes in dually infected
people that results in a mosaic genome composed
of regions from each of the different subtypes.When
these recombinants are transmitted and spread
within a population, they are recognized as circulat-
ing strains in the HIV epidemic and are classified as
CRFs [11]. The virus must be isolated from at least
two unlinked individuals and fully sequenced [12].
The designation ‘cpx’ (complex) is used when more
than three subtypes are present [13]. To date, 98
CRFs have been identified and updated in the Los
Alamos National Laboratory HIV sequence database
[14]. These are designated with sequential number-
ing as they are discovered and reported.
UNIQUE RECOMBINANT FORMS
Unique recombinant forms (URFs) consist of a mix-
ture of subtypes, but unlike the CRFs, they were
sampled only once from a single multiply-infected
individual [13]. Hence, all sequences corresponding
to a CRF have the same recombination break points
in the genome while each URF shows unique break-
points. Intrasubtype recombination does occur but
as it does not lead to subtype recombination, these
viruses are not described as URFs. Dual infections
with HIV-1 and HIV-2 have frequently been
reported in regions where both viruses circulate
[15] although no recombinants between them have
been described. Several AD and AC intersubtype
recombinants have been described in Eastern Africa
[16,17], where these three subtypes cocirculate. BF
intersubtype recombinants have been found in
Brazil and Argentina, where subtypes B and F are
both common [18,19]. Subtypes A and C cocirculate
in India with AC recombinants [20].
LITERATURE SEARCH
We performed a structured literature search in
PubMed using MeSH terms. A combination of key-
words related to the subject of ‘HIV genetic diversity
worldwide’ were used with Boolean operators (OR
andAND) in PubMed’s advanced search builder. The
results generated in the search builder at each level
were combined to output all articles that overlapped
across all the search words for the specified review
period (Fig. 1). This article focused mainly on HIV-1
as there was limited data on HIV-2 during the
review period.
GLOBAL DISTRIBUTION OF HIV-1 BY
REGION
Africa
The greatest genetic diversity of HIV-1 has been
found in Africa especially in West Central Africa
[21]; however, other parts of the continent show
an assortment of diverse viral strains. In Southern
Africa, subtype C collectively predominates [22,23],
whereas in Eastern Africa subtype A is the most
dominant [24
&&
] although other subtype D and C
viruses cocirculate as well [25]. An increase in sub-
type C and a decrease in subtype D have been
reported in Kenya together with extensive intersub-
type recombination [24
&&
]. A recent study in Uganda
reported an increased prevalence of HIV-1 intersub-
type recombinants of about 46% based on near full
length HIV sequences [26
&&
]. A separate study by the
Phylogenetic And Networks for Generalized HIV
Epidemics in Africa (PANGEA)-HIV consortium
[27
&
] showed a high proportion (about 50%) of
KEY POINTS
 Subtypes A, C and CRF02-AG are the most prevalent
on the African continent, whereas subtype B
predominates in Europe/the Americas and CRF01_AE
dominate in Asia.
 There is an increase in the prevalence of recombinant
viruses particularly in geographical areas where
multiple subtypes cocirculate such as Asia and Africa.
 The emerging and dynamic HIV genetic diversity needs
constant monitoring due to the challenges it presents
towards diagnosis, phylogenetic reconstruction,
treatment and vaccine development.
 The classification of HIV variants based on near full-
length genomes is still limited but needs to be scaled up
in a cost-effective way.
 The problem of missing HIV subtype data and low
sequence sampling levels needs to be addressed.
Phylogenetics in HIV transmission
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HIV-1 intersubtype recombinants in Uganda based
on deep sequencing of near full-length viral
genomes (unpublished data). In West and West
Central Africa, themajority of viruses are CRF02_AG
[21,28]. Subtypes A and G cocirculate in some coun-
tries such as Nigeria [21]. Mosaic viruses involving
CFR02_AG have been reported in several African
countries [29] and an increase of subtype F2 and
other recombinant forms in Cameroon [30] (Fig. 2).
Europe and North America
In North America [31], Europe [32–36] and Australia
[37], subtype B is still the most widespread viral
strain. Other subtypes have also been introduced.
For example, in Spain, subtype F1 was identified in a
cohort of MSM [38] or CRF02_AG among immigrant
populations [39].
South America
Subtype B predominates in South America [40,41].
Other intersubtype BF recombinants have also been
recently reported [42]. An increase in pure subtype C
compared with subtype B has also been reported
among HIV/viral hepatitis coinfected patients in
Southern Brazil [43].
FIGURE 1. Literature search. Diagrammatic representation of the literature search and selection of articles.
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Asia
Several subtypes circulate in Asia and it has been
described as the ‘hotbed’ of recombinant viruses
with several CRFs [44]. Subtype A predominates in
Russia and other former Soviet Union countries
although CRF02_AG is common in Kyrgyzstan
[45]. CRF01_AE and CRF07_BC predominate in
China [46–48]; new CRFs have been found in China
more than in any other country [49–52]. In south-
east Asia, CRF01-AE is the most prevalent [53,54]
while subtype C predominates in India with reports
of increased URFs in the north eastern part of the
country [55].
Middle East and North Africa
Middle East and North Africa countries are grouped
together because subtype B is the predominant sub-
type in the region and these countries show rela-
tively low prevalence and limited sampling of
infections [56
&
,57].
CONCLUSION
Previous reviews have shown that subtype C
accounts for more than 50% of all infections world-
wide with a concentration in East and Southern
Africa and India, CRF01_AE as the major strain
throughout Southeast Asia, CRF02_AG as the domi-
nant virus inWest Africa and about 30% of strains in
East Africa to consist of URFs [13,21]. However, there
is increased and extensive HIV-1 genetic diversity in
Asia [47,49–52,58] and Eastern Africa [24
&&
,26
&&
]. By
2010, there were about 45 reported CRFs [59], this
figure has more than doubled within a 7-year period
with at least 98 CRFs that have currently been
described [14]. This fast rate of increase in the prev-
alence of CRFs and the fact that several subtypes
cocirculate globally suggests that these numbers will
likely continue to grow in the future. The largest
source of HIV sequence data (subtype B) is from
Europe and the Americas with less data coming from
the Middle East (Table 1). As a result, HIV sequence
databases like Los Alamos [60] tend to represent a
biased sampling and therefore do not necessarily
reflect the distribution of subtypes worldwide. For
instance, subtype B accounted for 55% of HIV
sequences in the Los Alamos database [60] which
is about five times its frequency in the world [61].
Information on subtype diversity based on near full-
length genomes is still relatively scarce with major-
ity of the available data still based on partial HIV
fragments. In East Africa, classification of HIV based
on near full-length sequences showed a prevalence
FIGURE 2. Global distribution of major HIV subtypes. Map showing the global distribution of the major HIV subtypes and circulating
recombinant forms from the review. Source: Map of the world modified to show HIV-1 subtype diversity worldwide. Map-menu.com.
Phylogenetics in HIV transmission
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of 46% of recombinant viruses in Uganda [26
&&
]. The
classification of HIV variants based on near full-
length genomes is still relatively low (Table 1)
although some consortia have generated data that
spans entire HIV genomes [62]. One such consor-
tium is the PANGEA HIV [27
&
] which is a multina-
tional project funded by the Bill and Melinda
Gates Foundation to study the transmission
dynamics of HIV within generalized epidemics
in Africa. PANGEA aimed at generating close to
20 000 HIV near full-length sequences mainly
from sub-Saharan Africa which have been valuable
in characterizing HIV variants and understanding
the subtype diversity in several African countries.
Preliminary results have reported close to 50% of
HIV-1 intersubtype recombinants in Uganda based
on near full-length genomes (unpublished data
from PANGEA-HIV, [27
&
]).
Recent data suggest a significant increase in
the prevalence of recombinants in some countries
[26
&&
,55,63
&&
] and several newly discovered CRFs/
URFs in parts of Asia and Africa [49–52,58,59]. This
suggests that coinfection or superinfection by
divergent HIV-1 strains has become more common
in regions where multiple subtypes cocirculate
[26
&&
,42,49,52,64]. Viral sequences from recombi-
nant forms have been shown to affect the accuracy
of phylogenetic reconstructions [65,66]. This is
due to the different regions of the aligned recom-
binant genome having distinct evolutionary rela-
tionships that affect tree topology and branch
lengths [67]. Furthermore, such sequences introduce
errors in phylodynamic inferences [68] by biasing
ancestral state reconstruction and estimations for
themost recent common ancestor [65]. As the preva-
lence of recombinant forms increases, these chal-
lenges are expected to become more important for
molecular epidemiological-based investigations. The
scale up of cheaper near full-length genome sequenc-
ing approaches is critical in improving the accuracy
of viral classification. It is important to consider how
the fast-increasing emergence of HIV recombinant
forms will impact accurate diagnosis, phylogenetic
reconstruction, antiretroviral treatment and future
vaccine development.
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